Journal of Infectious Diseases & Therapy
Open Access

Research Article

The Effect of Intravenous Vancomycin in the Reduction of the Incidence of Clostridium difficile Colitis

Ghiath Bayasi^1*, Kimberly Barber², Amit Rama³, Matt Borr³ and Ferris Bayasi³

¹Department of Pulmonary/Critical Care, Genesys Regional Medical Center, Grand Blanc, MI, USA

²Department of Research, Genesys Regional Medical Center, Grand Blanc, MI, USA

³Department of Internal Medicine, Genesys Regional Medical Center, Grand Blanc, MI, USA

*Corresponding Author:

Ghiath Bayasi
Department of Pulmonary/Critical Care
Genesys Regional Medical Center
Grand Blanc, MI 48439, USA
Tel: 810-606-7878
Fax: 810-606-5882
E-mail: gbayasi@gmail.com

Received date: June 23, 2016; Accepted date: June 25, 2016; Published date: June 27, 2016

Citation: Bayasi G, Barber K, Rama A, Borr M, Bayasi F (2016) The Effect of Intravenous Vancomycin in the Reduction of the Incidence of Clostridium difficile Colitis. J Infect Dis Ther 4:286. doi:10.4172/2332-0877.1000286

Copyright: © 2016 Bayasi G, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

The gastrointestinal tract infection known as Pseudomembranous Colitis caused by bacteria Clostridium difficile (C. difficile). The massive overpopulation of C. difficile can result in conditions ranging from mildly debilitating antibiotic associated diarrhoea to life-threatening toxic mega-colon. This study will examine whether having Vancomycin as part of the antibiotic treatment regimen for various types of sepsis leads to a decreased incidence of antibiotic induced pseudomembranous colitis formation when compared to other antibiotic treatments alone without Vancomycin.

Keywords